About Galactoside alpha-(1,2)-fucosyltransferase 2
Galactoside alpha-(1,2)-fucosyltransferase 2 (FUT2) is a protein
from Homo sapiens identified by UniProt accession
Q10981, 343 residues long.
MolForge cross-references it against 0 known binders and
276 disease associations.
Target properties
| Protein name | Galactoside alpha-(1,2)-fucosyltransferase 2 |
| UniProt accession | Q10981 |
| Gene | FUT2 |
| Organism | Homo sapiens |
| Length | 343 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (276)
Diseases linked to this target (Open Targets).
- alkaline phosphatase measurement · score 0.42
- blood protein measurement · score 0.39
- low density lipoprotein cholesterol measurement · score 0.38
- vitamin B12 measurement · score 0.38
- type 1 diabetes mellitus · score 0.37
- breast milk measurement · score 0.37
- total cholesterol measurement · score 0.36
- Crohn's disease · score 0.36
- cholelithiasis · score 0.34
- cancer biomarker measurement · score 0.34
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q10981-F1 | alphafold | PREDICTED | 90.25 | — |
Amino-acid sequence (343 residues)
MLVVQMPFSF PMAHFILFVF TVSTIFHVQQ RLAKIQAMWE LPVQIPVLAS TSKALGPSQL RGMWTINAIG RLGNQMGEYA TLYALAKMNG RPAFIPAQMH STLAPIFRIT LPVLHSATAS RIPWQNYHLN DWMEEEYRHI PGEYVRFTGY PCSWTFYHHL RQEILQEFTL HDHVREEAQK FLRGLQVNGS RPGTFVGVHV RRGDYVHVMP KVWKGVVADR RYLQQALDWF RARYSSLIFV VTSNGMAWCR ENIDTSHGDV VFAGDGIEGS PAKDFALLTQ CNHTIMTIGT FGIWAAYLTG GDTIYLANYT LPDSPFLKIF KPEAAFLPEW TGIAADLSPL LKH
Explore Galactoside alpha-(1,2)-fucosyltransferase 2 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets